PMC:7195088 / 11430-11818 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"174","span":{"begin":223,"end":230},"obj":"Species"},{"id":"206","span":{"begin":149,"end":155},"obj":"Chemical"},{"id":"247","span":{"begin":292,"end":300},"obj":"Disease"},{"id":"248","span":{"begin":307,"end":312},"obj":"Disease"},{"id":"249","span":{"begin":325,"end":330},"obj":"Disease"}],"attributes":[{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"Tax:9606"},{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"MESH:D010100"},{"id":"A247","pred":"tao:has_database_id","subj":"247","obj":"MESH:D001247"},{"id":"A248","pred":"tao:has_database_id","subj":"248","obj":"MESH:D005334"},{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"MESH:D003371"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"mes and their tolerability.\nQuestion 7. What is the optimal timing of treatment initiation? Supportive therapy (symptomatic therapy, rehydration and oxygen supplementation, if necessary), should be initiated as soon as the patient manifests respiratory or systemic symptoms, including severe asthenia, high fever, persistent cough and/or clinical or radiologic signs of lung involvement. "}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":370,"end":374},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"mes and their tolerability.\nQuestion 7. What is the optimal timing of treatment initiation? Supportive therapy (symptomatic therapy, rehydration and oxygen supplementation, if necessary), should be initiated as soon as the patient manifests respiratory or systemic symptoms, including severe asthenia, high fever, persistent cough and/or clinical or radiologic signs of lung involvement. "}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T2","span":{"begin":241,"end":264},"obj":"Body_part"},{"id":"T3","span":{"begin":370,"end":374},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001004"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"mes and their tolerability.\nQuestion 7. What is the optimal timing of treatment initiation? Supportive therapy (symptomatic therapy, rehydration and oxygen supplementation, if necessary), should be initiated as soon as the patient manifests respiratory or systemic symptoms, including severe asthenia, high fever, persistent cough and/or clinical or radiologic signs of lung involvement. "}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":292,"end":300},"obj":"Phenotype"},{"id":"T11","span":{"begin":307,"end":312},"obj":"Phenotype"},{"id":"T12","span":{"begin":325,"end":330},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0025406"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0012735"}],"text":"mes and their tolerability.\nQuestion 7. What is the optimal timing of treatment initiation? Supportive therapy (symptomatic therapy, rehydration and oxygen supplementation, if necessary), should be initiated as soon as the patient manifests respiratory or systemic symptoms, including severe asthenia, high fever, persistent cough and/or clinical or radiologic signs of lung involvement. "}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T40","span":{"begin":241,"end":264},"obj":"http://purl.obolibrary.org/obo/UBERON_0001004"},{"id":"T41","span":{"begin":370,"end":374},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T42","span":{"begin":370,"end":374},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"mes and their tolerability.\nQuestion 7. What is the optimal timing of treatment initiation? Supportive therapy (symptomatic therapy, rehydration and oxygen supplementation, if necessary), should be initiated as soon as the patient manifests respiratory or systemic symptoms, including severe asthenia, high fever, persistent cough and/or clinical or radiologic signs of lung involvement. "}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T50","span":{"begin":149,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A50","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"mes and their tolerability.\nQuestion 7. What is the optimal timing of treatment initiation? Supportive therapy (symptomatic therapy, rehydration and oxygen supplementation, if necessary), should be initiated as soon as the patient manifests respiratory or systemic symptoms, including severe asthenia, high fever, persistent cough and/or clinical or radiologic signs of lung involvement. "}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T74","span":{"begin":28,"end":39},"obj":"Sentence"},{"id":"T75","span":{"begin":40,"end":91},"obj":"Sentence"},{"id":"T76","span":{"begin":92,"end":387},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"mes and their tolerability.\nQuestion 7. What is the optimal timing of treatment initiation? Supportive therapy (symptomatic therapy, rehydration and oxygen supplementation, if necessary), should be initiated as soon as the patient manifests respiratory or systemic symptoms, including severe asthenia, high fever, persistent cough and/or clinical or radiologic signs of lung involvement. "}